戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 in 94% of animals that were seropositive for bovine leukemia virus (BLV) (n = 63) and in 87% of BLV-s
2         The deltaretroviruses, which include bovine leukemia virus (BLV) and human T-cell leukemia vi
3 ing for the deltaretroviruses, which include bovine leukemia virus (BLV) and human T-cell leukemia vi
4 istent virus infections: sheep infected with Bovine Leukemia Virus (BLV) and humans infected with Hum
5 ly conserved envelope (Env) glycoproteins of bovine leukemia virus (BLV) and its close relative, huma
6 human endogenous retrovirus group K (HERVK), bovine leukemia virus (BLV) and mouse mammary tumor viru
7                                 In contrast, bovine leukemia virus (BLV) expresses subgenomic RNAP II
8    To investigate the early establishment of bovine leukemia virus (BLV) infection, we injected BLV-i
9 s) of animals with an early disease stage of bovine leukemia virus (BLV) infection, while IL-10 incre
10 MCs from animals with late disease stages of bovine leukemia virus (BLV) infection.
11                    The SU and TM proteins of bovine leukemia virus (BLV) initially were reported to b
12                                              Bovine leukemia virus (BLV) is a complex B-lymphotrophic
13                                              Bovine leukemia virus (BLV) is a deltaretrovirus that in
14                                              Bovine leukemia virus (BLV) is a member of the human T-c
15                                          The bovine leukemia virus (BLV) is an oncogenic retrovirus t
16                                   The Rex of bovine leukemia virus (BLV) is poorly characterized.
17                                              Bovine leukemia virus (BLV) is the causative agent of en
18 rved charged residues in the deltaretrovirus bovine leukemia virus (BLV) matrix (MA) and NC domains a
19 BMCs) infected with the oncogenic retrovirus bovine leukemia virus (BLV) produce virus when cultured
20  developed genetically simple derivatives of bovine leukemia virus (BLV) that can replicate in tissue
21                      The correlation between bovine leukemia virus (BLV) unintegrated DNA, viral expr
22                  The encapsidation signal of bovine leukemia virus (BLV) was previously shown by dele
23 ytoplasmic domain of the TM protein (CTM) of bovine leukemia virus (BLV) was regulated by two membran
24                                              Bovine leukemia virus (BLV), a retrovirus related to hum
25                 Here we demonstrate that the bovine leukemia virus (BLV), a retrovirus with an RNA ge
26                                              Bovine leukemia virus (BLV), a transactivating lymphotro
27  vivo mutation rate is comparable to that of bovine leukemia virus (BLV), another member of the HTLV/
28 herichia coli Shiga toxin (Stx) acts against bovine leukemia virus (BLV)-expressing cells was obtaine
29                                              Bovine leukemia virus (BLV)-induced persistent lymphocyt
30   Previously, we showed Stx activity against bovine leukemia virus (BLV)-infected cells in vitro and
31 iga toxin type 1 (Stx1) has activity against bovine leukemia virus (BLV).
32 ying the virus particle assembly pathway for bovine leukemia virus (BLV).
33 nuclear cells (PBMC) from cows infected with bovine leukemia virus (BLV).
34 ly important disease of cattle caused by the bovine leukemia virus (BLV).
35 on of B lymphocytes) in cattle infected with bovine leukemia virus (BLV; a retrovirus closely related
36 e in application method for the detection of bovine leukemia virus antigen gp51.
37                                              Bovine leukemia virus contains a pXBL region encoding th
38 e lentivirus and human T-cell leukemia virus/bovine leukemia virus genera.
39  for monocytes/macrophages in progression of bovine leukemia virus infection and, of importance, indi
40                                              Bovine leukemia virus microRNAs are strongly expressed i
41  region dispensable for in vivo infectivity, bovine leukemia virus microRNAs represent approximately
42 g of broad windows of small RNA sizes in the bovine leukemia virus ovine model of leukemia/lymphoma,
43 responsive element-independent expression of bovine leukemia virus RNA and supports the hypothesis th
44 scriptase PCR (RT-PCR) consistently detected bovine leukemia virus transcripts in fresh cells, and co
45              A recent demonstration that the bovine leukemia virus, a retrovirus, uses RNA polymerase
46 that peripheral blood mononuclear cells from bovine leukemia virus-infected animals in the alymphocyt
47 with previous findings suggest that IL-12 in bovine leukemia virus-infected animals may regulate prod
48 ipheral blood mononuclear cells (PBMCs) from bovine leukemia virus-infected animals with late-stage d